Innovation1 Biotech Inc. financial data

Location
Rockaway, NJ
Fiscal year end
31 August
Latest financial report
10-Q - Q1 2024 - 06 May 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 3.3% % 52%
Debt-to-equity -148% % -180%
Return On Equity 247% %
Return On Assets -520% % -332%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 22,470,239 shares
Common Stock, Shares, Outstanding 22,470,239 shares 12%
Common Stock, Value, Issued $22,470 USD 12%
Weighted Average Number of Shares Outstanding, Basic 22,470,239 shares 12%
Weighted Average Number of Shares Outstanding, Diluted 22,470,239 shares 12%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense $110,030 USD -81%
Operating Income (Loss) $2,426,371 USD -39%
Nonoperating Income (Expense) $139,460 USD
Net Income (Loss) Attributable to Parent $5,298,181 USD 87%
Earnings Per Share, Basic -0.02 USD/shares 95%
Earnings Per Share, Diluted -0.02 USD/shares 95%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $107,527 USD
Assets, Current $118,777 USD -16%
Property, Plant and Equipment, Net $1,047 USD -50%
Assets $121,504 USD -97%
Accounts Payable, Current $354,622 USD 12%
Accrued Liabilities, Current $179,170 USD -68%
Liabilities, Current $2,903,799 USD 24%
Liabilities $3,458,861 USD 47%
Retained Earnings (Accumulated Deficit) $59,570,727 USD -11%
Stockholders' Equity Attributable to Parent $3,337,357 USD -326%
Liabilities and Equity $121,504 USD -97%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 22,470,239 shares 12%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $107,527 USD 105%
Depreciation $1,046 USD 0%
Additional Paid in Capital $56,202,816 USD 2.5%
Interest Expense $49,113 USD -267%